Hopp til innhold
NHI.no
Annonse

Misofoni: Diagnostikk

Innhold i artikkelen

Det finnes ingen prøver eller tester som kan bekrefte eller avkrefte tilstanden. Opplysningene som kommer frem i sykehistorien er viktige.

Man bør spesielt skille misofoni fra noen andre tilstander som for eksempel 

Annonse
  • Hyperakusis - som betyr kroppslig ubehag eller smerte ved en lydstyrke (volum) som de fleste ikke vil få ubehag av - altså styrkeavhengig og ikke knyttet til de spesielle lydene som utløser misofoni
  • Fonofobi - som betyr redsel for at enkelt lyder kan gi ubehag som øresus eller smerte
  • Tinnitus (øresus) - en opplevelse av lyd i ørene eller hodet uten at det finnes en ytre lydkilde

Utredning og behandling tilpasses individuelt og er gjerne tverrfaglig. Avhengig av behov kan flere ulike fagpersoner være involvert, som for eksempel fastlege, audiolog, audiopedagog eller psykolog.

Dette dokumentet er basert på det profesjonelle dokumentet Misofoni . Referanselisten for dette dokumentet vises nedenfor

  1. Swedo SE, Baguley DM, Denys D, et al. Consensus Definition of Misophonia: A Delphi Study. Front Neurosci. 2022; 16: 841816. PMID:35368272. PubMed
  2. Henry JA, Theodoroff SM, Edmonds C, et al. Sound Tolerance Conditions (Hyperacusis, Misophonia, Noise Sensitivity, and Phonophobia): Definitions and Clinical Management. Am J Audiol. 2022;31(3):513-527. PMID:35858241. PubMed
  3. Suhnan AP, Finch PM, Drummond PD. Hyperacusis in chronic pain: neural interactions between the auditory and nociceptive systems. Int J Audiol. 2017 Nov;56(11):801-809. PMID: 28685627 PubMed
  4. Williams ZJ, He JL, Cascio CJ, Woynaroski TG. A review of decreased sound tolerance in autism: Definitions, phenomenology, and potential mechanisms. Neurosci Biobehav Rev. 2021 Feb;121:1-17. PMID: 33285160 PubMed
  5. Ferrer-Torres A, Giménez-Llort L. Misophonia: A Systematic Review of Current and Future Trends in This Emerging Clinical Field. Int J Environ Res Public Health. 2022;19(11):6790. PMID:35682372 PubMed
  6. Vitoratou S, Hayes C, Uglik-Marucha N, et al. Misophonia in the UK: Prevalence and norms from the S-Five in a UK representative sample. PLoS One 2023; 18: e0282777. pmid:36947525 PubMed
  7. Dixon LJ, Schadegg MJ, Clark HL, et al. Prevalence, phenomenology, and impact of misophonia in a nationally representative sample of U.S. adults. J Psychopathol Clin Sci. 2024 Jul;133(5):403-412. PMID: 38780601 PubMed
  8. Brout JJ, Edelstein M, Erfanian M, et al. Investigating Misophonia: A Review of the Empirical Literature, Clinical Implications, and a Research Agenda. Front Neurosci. 2018 Feb 7;12:36. PMID: 29467604 PubMed
  9. Jastreboff PJ, Jastreboff MM. The neurophysiological approach to misophonia: Theory and treatment. Front Neurosci. 2023 Mar 23;17:895574. PMID: 37034168 PubMed
  10. Mattson SA, D'Souza J, Wojcik KD, et al. A systematic review of treatments for misophonia. Pers Med Psychiatry. 2023 Jul-Aug;39-40:100104. Epub 2023 May 3. PMID: 37333720 PubMed
  11. Kumar S, Tansley-Hancock O, Sedley W, Winston JS, Callaghan MF, Allen M, Cope TE, Gander PE, Bamiou DE, Griffiths TD. The Brain Basis for Misophonia. Curr Biol. 2017 Feb 20;27(4):527-533. PMID: 28162895 PubMed
  12. Kumar S, Dheerendra P, Erfanian M, Benzaquén E, Sedley W, Gander PE, Lad M, Bamiou DE, Griffiths TD. The Motor Basis for Misophonia. J Neurosci. 2021 Jun 30;41(26):5762-5770. PMID: 34021042 PubMed
  13. Cassiello-Robbins C, Anand D, McMahon K, et al. The Mediating Role of Emotion Regulation Within the Relationship Between Neuroticism and Misophonia: A Preliminary Investigation. Front Psychiatry. 2020 Aug 28;11:847. PMID: 33005154 PubMed
  14. Zai G, Dembo J, Levitsky N, Richter MA. Misophonia: A Detailed Case Series and Literature Review. Prim Care Companion CNS Disord. 2022;24(5):21cr03124. PMID:36179361. PubMed
  15. Dozier TH, Lopez M, Pearson C. Proposed Diagnostic Criteria for Misophonia: A Multisensory Conditioned Aversive Reflex Disorder. Front Psychol. 2017 Nov 14;8:1975. PMID: 29184520 PubMed
  16. Jastreboff PJ, Jastreboff MM. The neurophysiological approach to misophonia: Theory and treatment. Front Neurosci. 2023 Mar 23;17:895574. PMID: 37034168 PubMed
  17. Potgieter I, MacDonald C, Partridge L, Cima R, Sheldrake J, Hoare DJ. Misophonia: A scoping review of research. J Clin Psychol. 2019;75(7):1203-1218. PMID:30859581 PubMed
  18. Potgieter I, MacDonald C, Partridge L, et al. Misophonia: A scoping review of research. J Clin Psychol. 2019 Jul;75(7):1203-1218. Epub 2019 Mar 11. PMID: 30859581 PubMed
  19. Webb J. β-Blockers for the Treatment of Misophonia and Misokinesia. Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):13-14. PMID: 35029865 PubMed
  20. Smith EEA, Guzick AG, Draper IA, et al. Perceptions of various treatment approaches for adults and children with misophonia. J Affect Disord. 2022 Nov 1;316:76-82. Epub 2022 Aug 12. PMID: 35970326 PubMed
  21. Jastreboff, P. J., & Jastreboff, M. M. Treatments for Decreased Sound Tolerance (Hyperacusis and Misophonia). Seminars in Hearing, 35(2), 105–120. 2014. https://doi.org/10.1055/s-0034-1372527
  22. Schröder AE, Vulink NC, van Loon AJ, Denys DA. Cognitive behavioral therapy is effective in misophonia: An open trial. J Affect Disord. 2017 Aug 1;217:289-294. PMID: 28441620 PubMed
  23. Jager IJ, Vulink NCC, Bergfeld IO, van Loon AJJM, Denys DAJP. Cognitive behavioral therapy for misophonia: A randomized clinical trial. Depress Anxiety. 2020 Dec 18;38(7):708–18. PMID: 33336858 PubMed
  24. Henry JA, Theodoroff SM, Edmonds C, Martinez I, Myers PJ, Zaugg TL, Goodworth MC. Sound Tolerance Conditions (Hyperacusis, Misophonia, Noise Sensitivity, and Phonophobia): Definitions and Clinical Management. Am J Audiol. 2022 Sep;31(3):513-527. PMID: 35858241 PubMed
Annonse
Annonse